Search hospitals > California > Los Angeles
Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center
Claim this profileLos Angeles, California 90048
Global Leader in Lung Cancer
Global Leader in Tumors
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast Cancer
Conducts research for Cancer
99 reported clinical trials
21 medical researchers
Summary
Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center is a medical facility located in Los Angeles, California. This center is recognized for care of Lung Cancer, Tumors, Non-Small Cell Lung Cancer, Breast Cancer, Cancer and other specialties. Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center is involved with conducting 99 clinical trials across 144 conditions. There are 21 research doctors associated with this hospital, such as Monica Mita, MD, Andrew Hendifar, MD, Jun Gong, MD, and Jeremy D. Rudnick.Area of expertise
1Lung Cancer
Global LeaderEGFR positive
Stage IV
C797S positive
2Tumors
Global LeaderStage IV
EGFR positive
BRAF positive
Top PIs
Monica Mita, MDCedars-Sinai Medical Center7 years of reported clinical research
Expert in Breast Cancer
Studies Solid Tumors
22 reported clinical trials
37 drugs studied
Andrew Hendifar, MDCedars-Sinai Medical Center4 years of reported clinical research
Studies Pancreatic Cancer
Studies Adenocarcinoma
19 reported clinical trials
38 drugs studied
Jun Gong, MDCedars-Sinai Medical Center3 years of reported clinical research
Studies Colorectal Cancer
Studies Cancer
18 reported clinical trials
35 drugs studied
Jeremy D. RudnickCedars-Sinai Medical Center2 years of reported clinical research
Studies Brain Tumor
Studies Glioblastoma
12 reported clinical trials
26 drugs studied
Clinical Trials running at Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center
Non-Small Cell Lung Cancer
Breast Cancer
Tumors
Lung Cancer
Cancer
Pancreatic Cancer
Glioblastoma
Solid Tumors
Squamous Cell Carcinoma
Small Cell Lung Cancer
APL-101
for Lung Cancer
This trial is testing APL-101, a new drug, on patients with specific genetic changes in their cancer. These patients often don't respond to typical treatments. The drug aims to block a protein that helps cancer cells grow and spread.
Recruiting1 award Phase 211 criteria
PF-07248144
for Breast Cancer
This trial is testing a new cancer drug called PF-07248144. It aims to find the best dose and see if it works better alone or with other cancer drugs. The study focuses on cancer patients who may not be responding well to current treatments.
Recruiting1 award Phase 113 criteria
Brentuximab Vedotin + Pembrolizumab
for Advanced Cancers
This trial will find out whether brentuximab vedotin and pembrolizumab work together to treat different types of cancer. There will be several different types of cancer studied in the trial. The cancer must have spread to other parts of the body (metastatic). The study will also find out what side effects occur. A side effect is anything the treatment does besides treat cancer. This is a multi-cohort study.
Recruiting1 award Phase 27 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center?
Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center is a medical facility located in Los Angeles, California. This center is recognized for care of Lung Cancer, Tumors, Non-Small Cell Lung Cancer, Breast Cancer, Cancer and other specialties. Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center is involved with conducting 99 clinical trials across 144 conditions. There are 21 research doctors associated with this hospital, such as Monica Mita, MD, Andrew Hendifar, MD, Jun Gong, MD, and Jeremy D. Rudnick.